RobertSBlumMD

Neurology • Vallejo, CA

Physician

Join to view full profile

Are you Dr. Blum?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 14 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1416 Tennessee St
Ste 6
Vallejo, CA 94590
Phone+1 707-552-6633

Fax+1 707-552-0702
Is this information wrong?

Summary

Dr. Robert Blum, MD is a neurologist in Vallejo, California. He is currently licensed to practice medicine in California, Hawaii, and Florida.

Education & Training

Icahn School of Medicine at Mount SinaiResidency, Neurological Surgery, 1963 - 1965
New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Neurological Surgery, 1961 - 1963
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 1960 - 1961
M Health FairviewInternship, Transitional Year, 1959 - 1960
University of Rochester School of Medicine and DentistryClass of 1959

Certifications & Licensure

NY State Medical License 1961 - Present
CA State Medical License 1964 - 2020
HI State Medical License 1988 - 2018
FL State Medical License 1973 - 1998

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Publications & Presentations

PubMed

Directing astroglia from the cerebral cortex into subtype specific functional neurons.
Heinrich C, Blum R, Gascón S, Masserdotti G, Tripathi P, Sánchez R, Tiedt S, Schroeder T, Götz M, Berninger B> ;PLoS Biol.. 2010-05-18
Effect of casopitant, a novel neurokinin -1 (NK-1) receptor antagonist for prevention of chemotherapy induced nausea and vomiting (CINV), on the pharmacokinetics (PK) ...
Blum R, Adams LM, Johnson BM, Zhang K, Eberwein DJ, Allred AJ, Lebowitz PF> ;J. Clin. Oncol.. 2008-05-20
Accelerated fractionated radiation by concomitant boost (AFX-CB) with concurrent cis-platinum (CDDP) for advanced nasopharyngeal carcinoma.
Choi W, Huang H, Sachdeva G, Culliney B, Malamud S, Blum R, Schantz S, Li J, Nishihori T, Harrison LB, Hu K> ;J. Clin. Oncol.. 2006-06-20
Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report...
Giantonio BJ, Hochster H, Blum R, Wiernik PH, Hudes GR, Kirkwood J, Trump D, Oken MM> ;Invest New Drugs. 2001-01-01
Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.
Wasserheit C, Frazein A, Oratz R, Sorich J, Downey A, Hochster H, Chachoua A, Wernz J, Zeleniuch-Jacquotte A, Blum R, Speyer J> ;J. Clin. Oncol.. 1996-07-01
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Sout...
Loehrer PJ, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, Blum R> ;J. Clin. Oncol.. 1994-06-01
Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.
Johnson DH, Turrisi AT, Chang AY, Blum R, Bonomi P, Ettinger D, Wagner H> ;J. Clin. Oncol.. 1993-05-01
4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma.
Hochster HS, Green MD, Speyer J, Fazzini E, Blum R, Muggia FM> ;J. Clin. Oncol.. 1985-11-01
Effects of intravenous hyperalimentation during treatment in patients with small-cell lung cancer.
Weiner RS, Kramer BS, Clamon GH, Feld R, Evans W, Moran EM, Blum R, Weisenthal LM, Pee D, Hoffman FA> ;J. Clin. Oncol.. 1985-07-01
Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups.
Antman K, Suit H, Amato D, Corson J, Wood W, Proppe K, Harmon D, Carey R, Greenberger J, Blum R> ;J. Clin. Oncol.. 1984-06-01
Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
Chang, A., Yeap, B., Davis, T., Blum, R., Hahn, R., Khanna, O., Fisher, H., Rosenthal, J., Witte, R., Schinella, R., Trump, D.> ;J Clin Oncol. 1996 Aug
Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588).
Chang, A. Y., Tu, Z. N., Smith, J. L., Bonomi, P., Smith, T. J., Wiernik, P. H., Blum, R.> ;Invest New Drugs. 1995
Join now to see all